TM9SF4
Basic information
Region (hg38): 20:32109714-32167258
Links
Phenotypes
GenCC
Source:
- autism spectrum disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TM9SF4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 2 | 0 |
Variants in TM9SF4
This is a list of pathogenic ClinVar variants found in the TM9SF4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-32109747-A-G | not specified | Likely benign (Jun 24, 2022) | ||
20-32109751-C-T | not specified | Uncertain significance (Oct 14, 2023) | ||
20-32133032-T-C | not specified | Uncertain significance (Apr 12, 2024) | ||
20-32133086-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
20-32136120-A-T | not specified | Uncertain significance (Feb 27, 2024) | ||
20-32136138-A-G | not specified | Uncertain significance (Jun 29, 2023) | ||
20-32141553-A-G | not specified | Uncertain significance (Feb 21, 2024) | ||
20-32141848-G-C | not specified | Uncertain significance (Dec 01, 2022) | ||
20-32143008-C-A | not specified | Uncertain significance (Mar 07, 2024) | ||
20-32143015-T-C | TM9SF4-related disorder | Uncertain significance (Jan 06, 2023) | ||
20-32143025-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
20-32143033-A-T | not specified | Uncertain significance (May 04, 2022) | ||
20-32143069-C-T | not specified | Uncertain significance (Jan 06, 2023) | ||
20-32143084-C-G | TM9SF4-related disorder | Uncertain significance (Dec 27, 2023) | ||
20-32145169-A-T | not specified | Uncertain significance (Apr 22, 2022) | ||
20-32146809-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
20-32149688-C-A | not specified | Uncertain significance (Mar 21, 2023) | ||
20-32149726-C-T | Likely benign (Nov 01, 2024) | |||
20-32150826-G-T | not specified | Uncertain significance (Mar 06, 2023) | ||
20-32155166-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
20-32157794-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
20-32157854-G-A | not specified | Uncertain significance (May 08, 2024) | ||
20-32157875-G-A | Autism spectrum disorder | Likely benign (-) | ||
20-32158478-C-T | Likely benign (Nov 01, 2024) | |||
20-32158482-G-A | not specified | Uncertain significance (Nov 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TM9SF4 | protein_coding | protein_coding | ENST00000398022 | 18 | 57753 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000999 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.96 | 233 | 399 | 0.583 | 0.0000244 | 4234 |
Missense in Polyphen | 72 | 180.36 | 0.39921 | 1873 | ||
Synonymous | 1.58 | 133 | 158 | 0.840 | 0.0000102 | 1212 |
Loss of Function | 5.30 | 5 | 42.1 | 0.119 | 0.00000221 | 438 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000440 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Associates with proteins harboring glycine-rich transmembrane domains and ensures their efficient localization to the cell surface (PubMed:25999474). Regulates the assembly and activity of V-ATPase in colon cancer cells via its interaction with V-type proton ATPase subunit H (ATP6V1H) and contributes to V-ATPase-mediated pH alterations in cancer cells which play an important role in drug resistance and invasiveness of colon cancer cells (PubMed:25659576). Plays an important role in an atypical phagocytic activity of metastatic melanoma cells called cannibalism and is involved in the pH regulation of the intracellular vesicles in tumor cells (PubMed:19893578). {ECO:0000269|PubMed:19893578, ECO:0000269|PubMed:25659576, ECO:0000269|PubMed:25999474}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.136
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.41
Haploinsufficiency Scores
- pHI
- 0.279
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.632
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.881
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tm9sf4
- Phenotype
- skeleton phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- response to hypoxia;phagocytosis;cell adhesion;regulation of intracellular pH;vacuolar proton-transporting V-type ATPase complex assembly;positive regulation of protein exit from endoplasmic reticulum;protein localization to membrane;positive regulation of protein localization to cell surface
- Cellular component
- early endosome;Golgi apparatus;membrane;integral component of membrane
- Molecular function
- protein binding